| 1 |
Nang SC, Lin YW, Petrovic Fabijan A, Chang RYK, Rao GG, Iredell J, Chan HK, Li J. Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation. Clin Microbiol Infect 2023:S1198-743X(23)00046-0. [PMID: 36736661 DOI: 10.1016/j.cmi.2023.01.021] [Reference Citation Analysis]
|
| 2 |
Bajiya N, Dhall A, Aggarwal S, Raghava GPS. Advances in the field of phage-based therapy with special emphasis on computational resources. Brief Bioinform 2023;24:bbac574. [PMID: 36575815 DOI: 10.1093/bib/bbac574] [Reference Citation Analysis]
|
| 3 |
Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M, Boussettine R, Filali-Ansari N, Lahlou FA, Diawara I, Ennaji MM, Kettani-Halabi M. Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics (Basel) 2022;11. [PMID: 36551487 DOI: 10.3390/antibiotics11121826] [Reference Citation Analysis]
|
| 4 |
Laucirica DR, Stick SM, Garratt LW, Kicic A. Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases. Front Med (Lausanne) 2022;9:1069929. [PMID: 36590945 DOI: 10.3389/fmed.2022.1069929] [Reference Citation Analysis]
|
| 5 |
Shen X, Zhang Y, Mao Q, Huang Z, Yan T, Lin T, Chen W, Wang Y, Cai X, Liang Y. Peptide–Polymer Conjugates: A Promising Therapeutic Solution for Drug-Resistant Bacteria. International Journal of Polymer Science 2022;2022:1-18. [DOI: 10.1155/2022/7610951] [Reference Citation Analysis]
|
| 6 |
Nakatsu CH, Pavlovic NB, Byappanahalli MN. Bacteria common to rhizosphere communities of Asiatic bittersweet across a post-glacial landscape. Front Ecol Evol 2022;10. [DOI: 10.3389/fevo.2022.999099] [Reference Citation Analysis]
|
| 7 |
Osei EK, Mahony J, Kenny JG. From Farm to Fork: Streptococcus suis as a Model for the Development of Novel Phage-Based Biocontrol Agents. Viruses 2022;14:1996. [PMID: 36146802 DOI: 10.3390/v14091996] [Reference Citation Analysis]
|
